Boston Private Bank & Trust’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$9.34M Sell
58,437
-307
-0.5% -$48.4K 0.43% 78
2014
Q4
$9.36M Sell
58,744
-800
-1% -$125K 0.43% 77
2014
Q3
$8.36M Sell
59,544
-60
-0.1% -$7.83K 0.41% 78
2014
Q2
$7.05M Buy
59,604
+5,054
+9% +$585K 0.34% 91
2014
Q1
$6.73M Buy
54,550
+49
+0.1% +$5.94K 0.34% 94
2013
Q4
$6.22M Sell
54,501
-730
-1% -$83K 0.31% 101
2013
Q3
$6.18M Buy
55,231
+245
+0.4% +$26.6K 0.34% 96
2013
Q2
$5.42M Buy
+54,986
New +$5.71M 0.32% 96

Other funds holding AMGN

Boston Private Bank & Trust's AMGN Position: Q1 2015 in Review

Boston Private Bank & Trust reduced its Amgen (AMGN) stake by 0.52% in Q1 2015, selling an estimated $48.4K and leaving 58,437 shares worth $9.34M. The position accounts for 0.43% of the portfolio, ranked #78.

Boston Private Bank & Trust first reported a position in AMGN in Q2 2013 and has held it in 8 quarters since. The position peaked at $9.36M in Q4 2014. 1,345 funds tracked by Wall St. Rank hold AMGN as of Q1 2015.

  • Boston Private Bank & Trust held 58,437 shares of Amgen worth $9.34M as of Q1 2015.
  • Boston Private Bank & Trust sold 307 Amgen shares in Q1 2015, an estimated $48.4K.
  • Amgen made up 0.43% of Boston Private Bank & Trust's portfolio in Q1 2015, its #78 holding.
  • Boston Private Bank & Trust first reported a position in Amgen in Q2 2013 and has held it in 8 quarters since.
  • Boston Private Bank & Trust's Amgen position peaked at $9.36M in Q4 2014.
  • 1,345 funds tracked by Wall St. Rank held Amgen as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.